2026年全球精準癌症影像市場報告

近年來，精準癌症影像市場發展迅速。預計該市場規模將從2025年的173.9億美元成長到2026年的195.8億美元，年複合成長率達12.6%。這一成長主要歸功於癌症患者數量的增加、分子成像技術的進步、PET和MRI系統的廣泛應用、醫院診斷基礎設施的擴建以及政府主導的癌症篩檢計畫。

預計未來幾年精準癌症影像市場將快速成長，到2030年將達到317.1億美元，複合年成長率（CAGR）為12.8%。預測期內的成長要素包括：對個人化癌症治療的需求不斷成長、人工智慧影像分析的擴展、精準醫學研究投入的增加、雲端影像平台的日益普及以及非侵入性診斷解決方案的進步。預測期內的關鍵趨勢包括：精準腫瘤影像技術​​的應用、混合影像系統的整合、多模態診斷工作流程、基於放射組學的腫瘤表徵以及早期癌症檢測技術的進步。

癌症患者數量的不斷成長預計將推動精準癌症成像市場的發展。這一成長主要源於人口老化，老年人由於基因突變的累積和長期暴露於各種風險因素，罹患癌症的風險更高。精準癌症影像透過實現早期檢測、更精確的腫瘤定位以及製定個人化治療方案，為癌症管理提供支持，從而改善治療效果並減少不必要的干預。例如，根據世界衛生組織 (WHO) 2024 年 2 月發布的報告，預計到 2050 年，新增癌症病例將超過 3,500 萬例，比 2022 年估計的 2,000 萬例增加 77%。因此，癌症病例的增加正在推動精準癌症影像市場的成長。

精準癌症影像市場的領導者正致力於利用人工智慧 (AI) 影像平台等創新技術，提高診斷準確率並簡化癌症治療計畫。 AI 影像平台是先進的 CT 和 MR 系統，利用機器學習演算法改進影像重建、腫瘤檢測和解剖視覺化，幫助臨床醫生更快、更準確地做出診斷，並制定更精準的癌症治療方案。例如，2025 年 9 月，皇家飛利浦公司 (Koninklijke Philips NV) 在美國放射腫瘤學會 (ASTRO) 2025 年會上發布了其最新的 CT 和 MR 解決方案，旨在推進精準癌症治療。這些平台具有超快速 AI 輔助重建、用於永續運作的無氦 MR 系統、寬視野 4D 成像以及直覺的介面，可簡化放射治療計劃並提高患者舒適度。這些創新技術將高品質影像與高效的工作流程相結合，使腫瘤科團隊更有信心、更精準地提供個人化治療。

目錄

第1章執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球精準癌症影像市場：吸引力評分及分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 數位化、雲端運算、巨量資料、網路安全
  • 物聯網、智慧基礎設施、互聯生態系統
  • 身臨其境型技術（AR/VR/XR）與數位體驗
• 主要趨勢
  • 精準腫瘤影像技術​​簡介
  • 混合成像系統的整合
  • 多模態診斷工作流程
  • 基於放射組學的腫瘤特徵分析
  • 早期癌症篩檢進展

第5章 終端用戶產業市場分析

• 醫院和診所
• 診斷影像中心
• 門診手術中心
• 癌症研究機構
• 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球精準癌症影像市場：PESTEL 分析
• 全球精準癌症影像市場：規模、對比及成長率分析
• 全球精準癌症影像市場表現：規模與成長，2020-2025年
• 全球精準癌症影像市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 按組件
• 硬體、軟體、服務
• 按癌症類型
• 乳癌、肺癌、攝護腺癌、大腸癌和其他癌症
• 透過影像診斷方法
• 磁振造影（MRI）、電腦斷層掃描（CT）、正子斷層掃描（PET）、單光子發射電腦斷層掃描（SPECT）和其他診斷方法。
• 透過使用
• 循環系統、神經、胃腸、感染疾病、腫瘤及其他應用領域
• 最終用戶
• 醫院、診所、診斷影像中心、門診手術中心和其他終端用戶
• 按類型細分：硬體
• 診斷影像系統、偵測設備、放射設備、切片檢查引導系統、監測設備
• 按類型細分：軟體
• 影像分析軟體、視覺化軟體、資料管理軟體、診斷軟體、報告產生軟體
• 按類型細分：服務
• 影像服務、諮詢服務、維修服務、訓練服務、整合服務

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 精準癌症影像市場：競爭格局及市場佔有率（2024年）
• 精準癌症影像市場：公司估值矩陣
• 精準癌症影像市場：公司概況
  • Hitachi Medical Corporation
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • FUJIFILM Holdings Corporation
  • Koninklijke Philips NV

第37章 其他大型企業和創新企業

• GE HealthCare Technologies Inc., Shimadzu Corporation, Agilent Technologies Inc., Mindray Bio-Medical Electronics Co Ltd., Bruker Corporation, Canon Medical Systems Corporation, Shanghai United Imaging Healthcare Co Ltd., Agfa-Gevaert NV, Hologic Inc., Carestream Health Inc., Perceptive Discovery, Esaote SpA, Alliance Medical Group, Quibim SL, Mediso Ltd

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 2030年精準癌症影像市場：蘊藏新機會的國家
• 2030年精準癌症影像市場：蘊藏新機會的細分領域
• 精準癌症影像市場展望（2030 年）：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Precision cancer imaging refers to an advanced medical imaging approach that utilizes highly accurate and targeted imaging techniques to detect, characterize, and monitor cancer at an early stage. It integrates modalities such as molecular imaging, functional imaging, and high-resolution anatomical imaging to improve diagnostic accuracy and support personalized cancer treatment planning.

The primary components of precision cancer imaging include hardware, software, and services. Hardware refers to advanced imaging equipment and systems utilized to capture high-resolution anatomical and functional images for accurate cancer detection and treatment planning. The types of cancer include breast cancer, lung cancer, prostate cancer, colorectal cancer, and other cancer types and the imaging modalities include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), single photon emission computed tomography (SPECT), and other modalities. They find application in cardiovascular, neurology, gastroenterology, infectious diseases, oncology, and other applications, serving end users including hospitals and clinics, diagnostic imaging centers, ambulatory surgical centers, and other end-users.

Tariffs are influencing the precision cancer imaging market by raising the cost of imported imaging equipment, semiconductor components, contrast agents, and advanced diagnostic software required for precision oncology diagnostics. This is slowing the procurement and deployment of MRI, CT, PET, and SPECT imaging systems, particularly in regions dependent on imported medical technologies such as Asia-Pacific and Latin America. Hardware-intensive segments such as imaging systems, detection devices, and radiation equipment are most affected due to global supply chain dependencies. However, tariffs are also encouraging local manufacturing, regional supplier diversification, and increased investment in domestic medical imaging technology ecosystems, creating long-term resilience in the market.

The precision cancer imaging market research report is one of a series of new reports from The Business Research Company that provides precision cancer imaging market statistics, including precision cancer imaging industry global market size, regional shares, competitors with a precision cancer imaging market share, detailed precision cancer imaging market segments, market trends and opportunities, and any further data you may need to thrive in the precision cancer imaging industry. This precision cancer imaging market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision cancer imaging market size has grown rapidly in recent years. It will grow from $17.39 billion in 2025 to $19.58 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to rising prevalence of cancer cases, advancements in molecular imaging technologies, increasing adoption of PET and MRI systems, expansion of hospital diagnostic infrastructure, growth in government cancer screening initiatives.

The precision cancer imaging market size is expected to see rapid growth in the next few years. It will grow to $31.71 billion by 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to increasing demand for personalized oncology treatments, expansion of AI-driven imaging analytics, growing investments in precision medicine research, rising adoption of cloud-based imaging platforms, increasing development of non-invasive diagnostic solutions. Major trends in the forecast period include precision oncology imaging adoption, hybrid imaging system integration, multi-modal diagnostic workflows, radiomics-based tumor characterization, early-stage cancer detection advancements.

The rising prevalence of cancer cases is expected to propel the growth of the precision cancer imaging market going forward. The rising prevalence of cancer cases is primarily due to an aging population, as older individuals have a higher risk of developing cancer because of the accumulation of genetic mutations and longer exposure to risk factors over time. Precision cancer imaging supports cancer management by enabling earlier detection, more accurate tumor localization, and personalized treatment planning that improves therapeutic outcomes and reduces unnecessary interventions. For instance, in February 2024, according to the World Health Organization, over 35 million new cancer cases are predicted in 2050, a 77% increase from the estimated 20 million cases in 2022. Therefore, the rising prevalence of cancer cases is driving the growth of the precision cancer imaging market.

Leading companies operating in the precision cancer imaging market are concentrating on leveraging innovative technologies such as artificial intelligence-built imaging platforms to enhance diagnostic accuracy and streamline cancer treatment planning. Artificial intelligence-built imaging platforms are advanced CT and MR systems that utilize machine learning algorithms to improve image reconstruction, tumor detection, and anatomical visualization, helping clinicians achieve faster, more accurate diagnoses and more precise cancer treatment planning. For instance, in September 2025, Koninklijke Philips N. V. unveiled its latest CT and MR solutions at the American Society for Radiation Oncology (ASTRO) 2025 meeting, specifically designed to advance precision cancer care. These platforms feature ultra-fast AI-assisted reconstruction, helium-free MR systems for sustainable operation, extended field-of-view 4D imaging, and intuitive interfaces that streamline radiation therapy planning and improve patient comfort. By combining high image quality with efficient workflows, these innovations enable oncology teams to deliver personalized treatment with greater confidence and precision.

In January 2025, Telix Pharmaceuticals Limited acquired ImaginAb Inc. for an undisclosed amount. Through this acquisition, Telix Pharmaceuticals aims to strengthen its radiopharmaceutical and precision oncology pipeline by integrating next-generation biologics and antibody-based imaging technologies to enhance target identification, improve therapeutic development capabilities, and accelerate its expansion in precision cancer diagnostics and therapy. ImaginAb Inc. is a US-based biotechnology company specializing in precision cancer imaging, focusing on immuno-oncology imaging to provide actionable insights for patient selection and treatment progress.

Major companies operating in the precision cancer imaging market are Hitachi Medical Corporation, Thermo Fisher Scientific Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Shimadzu Corporation, Agilent Technologies Inc., Mindray Bio-Medical Electronics Co Ltd., Bruker Corporation, Canon Medical Systems Corporation, Shanghai United Imaging Healthcare Co Ltd., Agfa-Gevaert N. V., Hologic Inc., Carestream Health Inc., Perceptive Discovery, Esaote S. p. A., Alliance Medical Group, Quibim S. L., Mediso Ltd

North America was the largest region in the precision cancer imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision cancer imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the precision cancer imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision cancer imaging market consists of revenues earned by entities by providing services such as tumor detection imaging services, cancer diagnosis and characterization services, image-guided biopsy support services, AI-based imaging analysis services, and treatment monitoring and response assessment services. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision cancer imaging market also includes sales of positron emission tomography (PET) tracers, computed tomography (CT) contrast agents, magnetic resonance imaging (MRI) contrast agents, ingle photon emission computed tomography (SPECT) radiotracers, and hybrid imaging systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Cancer Imaging Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses precision cancer imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision cancer imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision cancer imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Other Cancer Types
• 3) By Imaging Modality: Magnetic Resonance Imaging (MRI); Computed Tomography (CT); Positron Emission Tomography (PET); Single Photon Emission Computed Tomography (SPECT); Other Modalities
• 4) By Application: Cardiovascular; Neurology; Gastroenterology; Infectious Diseases; Oncology; Other Applications
• 5) By End-user: Hospitals And Clinics; Diagnostic Imaging Centers; Ambulatory Surgical Centers; Other End-users
• Subsegments:
• 1) By Hardware: Imaging Systems; Detection Devices; Radiation Equipment; Biopsy Guidance Systems; Monitoring Devices
• 2) By Software: Image Analysis Software; Visualization Software; Data Management Software; Diagnostic Software; Reporting Software
• 3) By Services: Imaging Services; Consulting Services; Maintenance Services; Training Services; Integration Services
• Companies Mentioned: Hitachi Medical Corporation; Thermo Fisher Scientific Inc.; Siemens Healthineers AG; FUJIFILM Holdings Corporation; Koninklijke Philips N.V.; GE HealthCare Technologies Inc.; Shimadzu Corporation; Agilent Technologies Inc.; Mindray Bio-Medical Electronics Co Ltd.; Bruker Corporation; Canon Medical Systems Corporation; Shanghai United Imaging Healthcare Co Ltd.; Agfa-Gevaert N.V.; Hologic Inc.; Carestream Health Inc.; Perceptive Discovery; Esaote S.p.A.; Alliance Medical Group; Quibim S.L.; Mediso Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Precision Cancer Imaging Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Precision Cancer Imaging Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Precision Cancer Imaging Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Precision Cancer Imaging Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.5 Immersive Technologies (AR/VR/XR) & Digital Experiences
• 4.2. Major Trends
  • 4.2.1 Precision Oncology Imaging Adoption
  • 4.2.2 Hybrid Imaging System Integration
  • 4.2.3 Multi-Modal Diagnostic Workflows
  • 4.2.4 Radiomics-Based Tumor Characterization
  • 4.2.5 Early-Stage Cancer Detection Advancements

5. Precision Cancer Imaging Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Diagnostic Imaging Centers
• 5.3 Ambulatory Surgical Centers
• 5.4 Cancer Research Institutes
• 5.5 Other End-users

6. Precision Cancer Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Precision Cancer Imaging Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Precision Cancer Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Precision Cancer Imaging Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Precision Cancer Imaging Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Precision Cancer Imaging Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Precision Cancer Imaging Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Precision Cancer Imaging Market Segmentation

• 9.1. Global Precision Cancer Imaging Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hardware, Software, Services
• 9.2. Global Precision Cancer Imaging Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Other Cancer Types
• 9.3. Global Precision Cancer Imaging Market, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Other Modalities
• 9.4. Global Precision Cancer Imaging Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Cardiovascular, Neurology, Gastroenterology, Infectious Diseases, Oncology, Other Applications
• 9.5. Global Precision Cancer Imaging Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Other End-users
• 9.6. Global Precision Cancer Imaging Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Imaging Systems, Detection Devices, Radiation Equipment, Biopsy Guidance Systems, Monitoring Devices
• 9.7. Global Precision Cancer Imaging Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Image Analysis Software, Visualization Software, Data Management Software, Diagnostic Software, Reporting Software
• 9.8. Global Precision Cancer Imaging Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Imaging Services, Consulting Services, Maintenance Services, Training Services, Integration Services

10. Precision Cancer Imaging Market Regional And Country Analysis

• 10.1. Global Precision Cancer Imaging Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Precision Cancer Imaging Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Precision Cancer Imaging Market

• 11.1. Asia-Pacific Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Precision Cancer Imaging Market

• 12.1. China Precision Cancer Imaging Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Precision Cancer Imaging Market

• 13.1. India Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Precision Cancer Imaging Market

• 14.1. Japan Precision Cancer Imaging Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Precision Cancer Imaging Market

• 15.1. Australia Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Precision Cancer Imaging Market

• 16.1. Indonesia Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Precision Cancer Imaging Market

• 17.1. South Korea Precision Cancer Imaging Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Precision Cancer Imaging Market

• 18.1. Taiwan Precision Cancer Imaging Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Precision Cancer Imaging Market

• 19.1. South East Asia Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Precision Cancer Imaging Market

• 20.1. Western Europe Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Precision Cancer Imaging Market

• 21.1. UK Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Precision Cancer Imaging Market

• 22.1. Germany Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Precision Cancer Imaging Market

• 23.1. France Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Precision Cancer Imaging Market

• 24.1. Italy Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Precision Cancer Imaging Market

• 25.1. Spain Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Precision Cancer Imaging Market

• 26.1. Eastern Europe Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Precision Cancer Imaging Market

• 27.1. Russia Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Precision Cancer Imaging Market

• 28.1. North America Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Precision Cancer Imaging Market

• 29.1. USA Precision Cancer Imaging Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Precision Cancer Imaging Market

• 30.1. Canada Precision Cancer Imaging Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Precision Cancer Imaging Market

• 31.1. South America Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Precision Cancer Imaging Market

• 32.1. Brazil Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Precision Cancer Imaging Market

• 33.1. Middle East Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Precision Cancer Imaging Market

• 34.1. Africa Precision Cancer Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Precision Cancer Imaging Market, Segmentation By Component, Segmentation By Cancer Type, Segmentation By Imaging Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Precision Cancer Imaging Market Regulatory and Investment Landscape

36. Precision Cancer Imaging Market Competitive Landscape And Company Profiles

• 36.1. Precision Cancer Imaging Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Precision Cancer Imaging Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Precision Cancer Imaging Market Company Profiles
  • 36.3.1. Hitachi Medical Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis

37. Precision Cancer Imaging Market Other Major And Innovative Companies

• GE HealthCare Technologies Inc., Shimadzu Corporation, Agilent Technologies Inc., Mindray Bio-Medical Electronics Co Ltd., Bruker Corporation, Canon Medical Systems Corporation, Shanghai United Imaging Healthcare Co Ltd., Agfa-Gevaert N.V., Hologic Inc., Carestream Health Inc., Perceptive Discovery, Esaote S.p.A., Alliance Medical Group, Quibim S.L., Mediso Ltd

38. Global Precision Cancer Imaging Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Precision Cancer Imaging Market

41. Precision Cancer Imaging Market High Potential Countries, Segments and Strategies

• 41.1 Precision Cancer Imaging Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Precision Cancer Imaging Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Precision Cancer Imaging Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer